> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Bill to Reduce Dependence on China Drugs
- URL: https://www.fdaweb.com/bill-to-reduce-dependence-on-china-drugs/
- Published: 2023-10-27T12:00:00.000Z
- Updated: 2026-09-14T14:14:34.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5155666

Senator **Marco Rubio** (R-FL) has introduced a bill entitled [Further Strengthening America’s Supply Chains and National Security Act](https://www.rubio.senate.gov/wp-content/uploads/2023/10/Further-Strengthening-Americas-Supply-Chains-and-National-Security-Act.pdf?ref=fdaweb.com) to reduce America’s dependence on China for pharmaceuticals and to address related supply chain risks that lead to shortages of critical drugs.

“The COVID-19 pandemic highlighted how vulnerable America’s supply chains are,” Rubio said in a [news release](https://www.rubio.senate.gov/rubio-colleagues-introduce-bill-to-end-u-s-medical-supply-chain-dependence-on-china-address-shortages/?ref=fdaweb.com). “Three years later, we continue to be victims of a pharmaceutical supply chain that has been sent overseas. We cannot continue down this path; that is why I am introducing the Further Strengthening America’s Supply Chains and National Security Act to put an end to America’s dependence on other countries for key drugs.”

The legislation would:

- Close a loophole created by the court decision in *Acetris Health, LLC v. United States* that allowed drugs with foreign active ingredients to qualify for government procurement as though they were drugs made in the U.S.
- Amend FDA’s foreign inspection risk factors to improve oversight of facilities in China and other countries with questionable drug manufacturing quality standards.
- Require drug makers to share more information with FDA about where pharmaceutical ingredients are sourced.